Fundamentals of retarding penetration

Percutaneous Penetration Enhancers, Second Edition

Volumn , Issue , 2005, Pages 361-371

  Hadgraft, Jonathan ^a   Finnin, Barrie C ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057257909     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. M. Schlumpf, H. Jarry, W. Wuttke, R. Ma, and W. Lichtensteiger. Estrogenic activity and estrogen receptor [beta] binding of the UV filter 3-benzylidene camphor: comparison with 4-methylbenzylidene camphor. Toxicology 199: 109-120 (2004).
2. G. Briassoulis, M. Narlioglou, and T. Hatzis. Toxic encephalopathy associated with use of DEET insect repellents: a case analysis of its toxicity in children. Human and Experimental Toxicology 20: 8-14 (2001).
3. E.L. Baker, M. Zack, J.W. Miles, L. Alderman, M. Warren, R.D. Dobbin, S. Miller, and W.R. Teeters. Epidemic malathion poisoning in Pakistan malaria workers. The Lancet 311: 31-34(1978).
4. A.E. Watterson. Regulating pesticides in the UK: a case study of risk management problems relating to the organophosphate diazinon. Toxicology Letters 107: 241-248 (1999).
5. J.A. Bouwstra, G.S. Gooris, D. Downing, and W. Bras. The sructure of pig stratum-corneum -a wide and small-angle x-ray study. Biophysical Journal 64: A295-A295 (1993).
6. A. Al-Amoudi, L.P.O. Norlen, and J. Dubochet. Cryo-electron microscopy of vitreous sections of native biological cells and tissues. Journal of Structural Biology. In press.
7. J. Hadgraft. Skin, the final frontier. International Journal of Pharmaceutics 224: 1-18 (2001).
8. K.D. McCarley and A.L. Bunge. Absorption into silicone rubber membranes from powders and aqueous solutions. International Journal of Pharmaceutics 250: 169-180 (2003).
9. W.J. Albery and J. Hadgraft. Percutaneous absorption: in vivo experiments. Journal of Pharmacy and Pharmacology 31: 140-147 (1979).
10. R.O. Potts and M.L. Francoeur. The influence of stratum-corneum morphology on water permeability. Journal of Investigative Dermatology 96: 495-499 (1991).
11. C.L. Gay, T.M. Murphy, J. Hadgraft, I.W. Kellaway, J.C. Evans, and C.C. Rowlands. An electron spin resonance study of skin penetration enhancers. International Journal of Pharmaceutics 49: 39-45 (1989).
12. R. J. Feldman and H. I. Maibach. Regional variation in percutaneous penetration of 14C cortisol in man. Journal of Investigative Dermatology 48: 181-183 (1967).
13. T. Higuchi. Physical chemical analysis of percutaneous absorption process from creams and ointments. Journal of the Society of Cosmetic Chemists 11: 85-97 (1960).
14. J. N. Twist and J. L. Zatz. Influence of solvents on paraben permeation through idealized skin model membranes. Journal of the Society of Cosmetic Chemists 37: 429 -444 (1986).
15. U. Berndt, W. Wigger-Alberti, B. Gabard, and P. Elsner. Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis 42: 77-80 (2000).
16. D. Perrenoud, D. Gallezot, and G. van Melle. The efficacy of a protective cream in a real-world apprentice hairdresser environment. Contact Dermatitis 45: 134-138 (2001).
17. R. P. Chilcott, J. Jenner, S. A. Hotchkiss, and P. Rice. Evaluation of barrier creams against sulfur mustard. I. In vitro studies using human skin. Skin Pharmacology and Applied Skin Physiology 15: 225-235 (2002).
18. D. K. Liu, R. W. Wannemacher, T.H. Snider, and T. L. Hayes. Efficacy of the topical skin protectant in advanced development. Journal of Applied Toxicology 19: S41-S45 (1999).
19. J. Kresken and A. Klotz. Occupational skin-protection products -a review. International Archives of Occupational and Environmental Health 76: 355-358 (2003).
20. I. Steinstrasser and H. P. Merkle. Dermal metabolism of topically applied drugs: pathways and models reconsidered. Pharmaceutica Acta Helvetiae 70: 3-24 (1995).
21. S. Selim, J. Hartnagel, E. Ralph, T. G. Osimitz, K. L. Gabriel, and G. P. Schoenig. Absorption, metabolism, and excretion of N, N-diethyl-m-toluamide following dermal application to human volunteers. Fundamental and Applied Toxicology 25: 95-100 (1995).
22. R. U. Pendlington, D. L. Williams, J. T. Naik, and R. K. Sharma. Distribution of xenobiotic metabolizing enzymes in skin. Toxicology in Vitro 8: 525-527 (1994).
23. R. J. Martin, S. P. Denyer, and J. Hadgraft. Skin metabolism of topically applied compounds. International Journal of Pharmaceutics 39: 23-32 (1987).
24. K. D. McCarley and A. L. Bunge. Pharmacokinetic models of dermal absorption. Journal of Pharmaceutical Sciences 90: 1699-1719 (2001).
25. J. W. Hadgraft and G. F. Somers. Percutaneous absorption. Journal of Pharmacy and Pharmacology 8: 625-634 (1956).
26. R. O. Potts and R. H. Guy. Predicting skin permeability. Pharmaceutical Research 9: 663-669 (1992).
27. S. H. Yalkowsky and S. C. Valvani. Solubility and partitioning I: solubility of nonelectrolytes in water. Journal of Pharmaceutical Sciences 69(8): 912-922 (1980).
28. J. Hadgraft and C. Valenta. pH, pK(a), and dermal delivery. International Journal of Pharmaceutics 200: 243-247 (2000).
29. C. Valenta, U. Siman, M. Kratzel, and J. Hadgraft. The dermal delivery of lignocaine: influence of ion pairing. International Journal of Pharmaceutics 197: 77-85 (2000).
30. W. J. Pugh, M. S. Roberts, and J. Hadgraft. Epidermal permeability -penetrant structure relationships. 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. International Journal of Pharmaceutics 138: 149-165 (1996).
31. M. S. Roberts, W. J. Pugh, and J. Hadgraft. Epidermal permeability: penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. International Journal of Pharmaceutics 132: 23-32 (1996).
32. B. C. Finnin and T. M. Morgan. Transdermal penetration enhancers: applications, limitations, and potential. Journal of Pharmaceutical Sciences 88: 955-958 (1999).
33. R. C. Wester, M. Mobayen, and H. I. Maibach. In vivo and in vitro absorption and binding to powdered stratum corneum as methods to evaluate skin absorption of environmental chemical contaminants from ground and surface water. Journal of Toxicology and Environmental Health 21: 367-374 (1987).
34. P. Perugini, S. Simeoni, S. Scalia, I. Genta, T. Modena, B. Conti, and F. Pavanetto. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexylp-methoxycinnamate. International Journal of Pharmaceutics 246: 37-45 (2002).
35. R. Alvarez-Roman, G. Barre, R. H. Guy, and H. Fessi. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. European Journal of Pharmaceutics and Biopharmaceutics 52: 191-195 (2001).
36. A. F. Davis and J. Hadgraft. Supersaturated solutions as topical drug delivery systems. In K. A. Walters and J. Hadgraft (eds), Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 1993, pp. 243-267.
37. M. A. Pellett, A. F. Davis, and J. Hadgraft. Effect of supersaturation on membrane transport 2. Piroxicam. International Journal of Pharmaceutics 111: 1-6 (1994).
38. N. A. Megrab, A. C. Williams, and B. W. Barry. Oestradiol permeation across human skin, silastic and snake skin membranes -the effects of ethanol water co-solvent systems. International Journal of Pharmaceutics 116: 101-112 (1995).
39. K. Moser, K. Kriwet, C. Froehlich, Y. N. Kalia, and R. H. Guy. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug. Pharmaceutical Research 18: 1006-1011 (2001).
40. K. Moser, K. Kriwet, Y. N. Kalia, and R. H. Guy. Stabilization of supersaturated solutions of a lipophilic drug for dermal delivery. International Journal of Pharmaceutics 224: 169-176 (2001).
41. S. L. Raghavan, A. Trividic, A. F. Davis, and J. Hadgraft. Crystallization of hydrocortisone acetate: influence of polymers. International Journal of Pharmaceutics 212: 213-221 (2001).
42. S. L. Raghavan, B. Kiepfer, A. F. Davis, S. G. Kazarian, and J. Hadgraft. Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers. International Journal of Pharmaceutics 221: 95-105 (2001).
43. B. W. Barry. Dermatological formulations: percutaneous absorption. In J. Swarbrick (ed.), Drugs and the Pharmaceutical Sciences, Vol. 18, Marcel Dekker, New York and Basel, 1983, p. 480
44. Z. Liron and S. Cohen. Percutaneous absorption of alkanoic acids II: application of regular solution theory. Journal of Pharmaceutical Sciences 73: 538-542 (1984).
45. J. C. Beastall, J. Hadgraft, and C. Washington. Mechanism of action of azone as a percutaneous penetration enhancer: lipid bilayer fluidity and transition temperature effects. International Journal of Pharmaceutics 43: 207-213 (1988).
46. B. Ongpipattanakul, R. R. Burnette, R. O. Potts, and M. L. Francoeur. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharmaceutical Research 8: 350-354 (1991).
47. J. Hadgraft, J. Peck, D. G. Williams, W. J. Pugh, and G. Allan. Mechanisms of action of skin penetration enhancers retarders: Azone and analogues. International Journal of Pharmaceutics 141: 17-25 (1996).